Gregg C. Johnson
CIK: 0001135957
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 14, 2026VVOS
Vivos Therapeutics, Inc.
Award(A)DirectStock Options (Right to Buy)
12K shares- - Jun 22, 2026VTSI
VirTra, Inc
Award(A)Direct2.8K shares- - Oct 13, 2025VTSI
VirTra, Inc
Award(A)Direct4K shares- - Oct 18, 2024VTSI
VirTra, Inc
Award(A)Direct4.5K shares-
1-4 of 4 transactions
About JOHNSON GREGG C
JOHNSON GREGG C (SEC CIK 0001135957) files insider reports with the SEC as Director of Vivos Therapeutics, Inc. (VVOS) and Director of VirTra, Inc (VTSI).
Signal8 holds 5 ownership filings by JOHNSON GREGG C (1 Form 3, 4 Form 4), filed between Oct 22, 2024 and Sep 18, 2026. Those filings report 4 transactions, from Oct 18, 2024 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on JOHNSON GREGG C's filings is in LITTLETON, CO.
Recent filings by JOHNSON GREGG C
Other insiders filing for Vivos Therapeutics, Inc. (VVOS)
- Krammer Anja B, Director
- Lindsay Mark F., Director
- Green Ralph Elias, Director
- SOKOLOW LEONARD J, Director
- Huntsman Ronald Kirk, Chief Executive Officer
- Amman Bradford K., Principal Accounting Officer